Eli Lilly and Company
CorpDigest
Eli Lilly and Company
Annual Revenue
Last reviewed: 2026-06-03 · By Swet Parvadiya
FY2021 Revenue
$28.3B
▲ 15.5% vs FY2020 ($24.5B)
Eli Lilly and Company reported $28.3B in revenue for fiscal year 2021. This represents a growth of 15.5% compared to the 2020 figure of $24.5B. In 2022, revenue increased to $28.5B.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2024 | $45.0B | $10.6B | +31.9% |
| FY2023 | $34.1B | — | +19.6% |
| FY2022 | $28.5B | — | +0.8% |
| FY2021 | $28.3B | — | +15.5% |
| FY2020 | $24.5B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.